Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001564590-19-009631
Filing Date
2019-03-28
Accepted
2019-03-27 17:53:33
Documents
69
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 10-K nvus-10k_20181231.htm 10-K 2415054
2 EX-10.15 nvus-ex1015_385.htm EX-10.15 422358
3 EX-21.1 nvus-ex211_11.htm EX-21.1 3378
4 EX-23.1 nvus-ex231_10.htm EX-23.1 6843
5 EX-31.1 nvus-ex311_12.htm EX-31.1 11351
6 EX-31.2 nvus-ex312_15.htm EX-31.2 11494
7 EX-32.1 nvus-ex321_14.htm EX-32.1 7083
8 EX-32.2 nvus-ex322_13.htm EX-32.2 7109
9 GRAPHIC gyrfs3gjeyn5000001.jpg GRAPHIC 257086
10 GRAPHIC gsxv5kzvjclq000002.jpg GRAPHIC 14552
11 GRAPHIC gyrfs3gjeyn5000002.jpg GRAPHIC 30272
12 GRAPHIC gsxv5kzvjclq000001.jpg GRAPHIC 25790
  Complete submission text file 0001564590-19-009631.txt   8289473

Data Files

Seq Description Document Type Size
13 XBRL INSTANCE DOCUMENT nvus-20181231.xml EX-101.INS 1413814
14 XBRL TAXONOMY EXTENSION SCHEMA nvus-20181231.xsd EX-101.SCH 56662
15 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nvus-20181231_cal.xml EX-101.CAL 54272
16 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nvus-20181231_def.xml EX-101.DEF 149775
17 XBRL TAXONOMY EXTENSION LABEL LINKBASE nvus-20181231_lab.xml EX-101.LAB 436354
18 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nvus-20181231_pre.xml EX-101.PRE 318754
Mailing Address 19900 MACARTHUR BLVD. SUITE 550 IRVINE CA 92612
Business Address 19900 MACARTHUR BLVD. SUITE 550 IRVINE CA 92612 949-238-8090
Novus Therapeutics, Inc. (Filer) CIK: 0001404281 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36620 | Film No.: 19709318
SIC: 2834 Pharmaceutical Preparations